Please login to the form below

Not currently logged in
Email:
Password:

Verily's Baseline health project seeks 10,000 volunteers

Four-year study to produce a molecular snapshot

Verily

Alphabet's life sciences unit Verily has kicked off a project that will examine the risk factors that come into play as a person moves from health to sickness.

The initiative comes under the Verily (formerly Google Life Sciences) Project Baseline, which is trying to establish a reference standard for good health so that it will become possible to identify deviations from that standard which serves as early warning signals for disease. Added to that, the company hopes the project will create ‘a new set of tools for medical discovery’.

With the help of Duke University and Stanford Medicine in the US, Verily intends to recruit 10,000 volunteers who will undergo a battery of sampling and measurements - spanning clinical, molecular, imaging, sensor, self-reported, behavioural, psychological and environmental factors - over a four-year period.

The aim is to profile the volunteers' genetics, protein make-up and the like - in a kind of molecular snapshot - but will also try to tie in new technologies such as wearables to understand them at a digital level, according to Dr Jessica Mega, Verily's chief medical officer.

As well as providing biological samples, the recruits - who will include people who are exceptionally healthy, at-risk of disease and with overt disease - will wear a newly-developed Verily study watch that measures electrocardiogram (ECG) and heart rate, electrodermal activity and activity levels, and will automatically upload data to the cloud.

Volunteers will also use a new mobile app, have their sleep monitored using a special bed and take part in regular surveys.

"We are creating an infrastructure that can process multi-dimensional health data - much of which have never been combined for an individual,” said Mega in a blog post. "In the future, the intent is to make de-identified data from the Project Baseline study available to qualified researchers to spur new ideas across the broad ecosystem."

The new Verily watch will also be deployed in some of Verily's other initiatives including its Personalized Parkinson's Project with Radboud University in the Netherlands, which is attempting to identify biological markers that will reduce the progression of the disease - as well as potentially the impact of drug treatments - to be tracked more sensitively.

Article by
Phil Taylor

20th April 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Complete HealthVizion

Complete HealthVizion is a global team of fresh thinkers who aspire to be better every day. We create life-changing medical...

Latest intelligence

Digital
Tools for the digital world
The next step for the pharma industry...
How Can We Make Payer Communications Really Sing?
With so many different influences at play in access decisions, how can we make sure we tap into what’s really driving payer decision-making. How do we go beyond the stated...
Harnessing the power of core elements to optimise market access
This article by John Spoors and Anton Abrahams focuses on optimising market access – the RJW and Solaris Health teams operate across all major markets, where the principles set out...

Infographics